SlideShare a Scribd company logo
1 of 38
VIGNAN PHARMACY COLLEGE,
VADLAMUDI
A case study
on
PNEUMONIA and TUBERCULOSIS
By
B.NOM KUMAR NAIK,
17AB1T0005.
CASE STUDY
● A 77 years old male patient was admitted in hospital with chief
complaints of Cough with Hemoptysis, decreased apatite and known
case of Pulmonary Koch's with Secondary pneumonia
( Fungal - Candida + Klebsiella pneumonia )
S O A P NOTES :
Patient details : -
Name : - xxx Age : - 77 years Gender : - Male
Subjective evidences :
Chief complaints :
❑ Cough with Hemoptysis ,
❑ Decreased apatite .
Past history :
1. Hypertension,
2. Diabetes mellitus - 2,
3. Diabetic nephropathy with severe proteinuria,
4. Anemia
5. Generalized surgical emphysema
6. Hepatitis ( ATT Induced )
7. Hypokalemia - improved .
Past medical history :
1. Inj.Colistin - 1miu ….IV…..TID
2. Inj.Clindamycin - 600mg ….IV….TID
3. Inj.Capsofungin - OD
4. ATT Regimen
5. Tab.Atraconazole - 400mg….IOB
Family history :
● NIL.
Allergies :
● Not known
● Ex - Smoker,
● Ex - Alcoholic.
Social / personal history :
1.Vitals :
Objective evidences :
● B.P : - 160/90mm Hg
● R.R : - 15Cycles/min
● P.R : - 106 Beats/min
● Temp : - 98.6 F
● SpO2 : - 82 %
● Height : - 160cm
● Weight : - 90 kg
● BMI : - 35.2 ( Obese )
2.Clinical examinations :
 RS : BAE +
 Abdomen : Soft
 CVS : S1 , S2 +
 CNS : C & C
3.Investigations :
1. COMPLETE BLOOD COUNT ( CBC )
2. SERUM ELECTROLYTES
3. LIVER FUNCTION TEST ( LFT )
4. BED SIDE ECHO
5. CT CHEST PLAIN
6. CHEST X - RAY
7. SPUTUM SAMPLE TEST
8. ECG
9. PLEURAL FLUID FOR LDH
10.RANDOM BLOOD SUGAR
11.C - REACTIVE PROTEIN.
COMPLETE BLOOD COUNT : -
Parameters Observed value Normal value
WBC 3,400cells/cumm 4000- 11000cells/cumm
Haemoglobin 8.8g/dL 12.0 - 15.0 g/L
Day : - 1
Parameters Observed value Normal value
Sodium 131 mmol/L 135.0 - 145 mmol/ L
Potassium 2.8 mmol/ L 3.5 - 4.5 mmol/L
Serum creatinine 1.0mg/dl 0.7 - 1.2 mg/dl
SERUM ELECTROLYTES: -
SERUM ELECTROLYTES : -
Parameters Observed value Normal value
Sodium 131 mmol/L 135.0 - 145 mmol/ L
Day : - 2
LIVER FUNCTION TEST : -
Parameters Observed value Normal value
Total bilirubin 1.9mg/dL 0.2 - 1.3mg / dL
BED SIDE ECHO : -
● Very poor echo windo
● Mild concentric LVH
● No obvious RWMA
● Grade - 1 Diastolic dysfunction of LVH
● AV Sclerosis / TriviLAAR
● Mild TR / Moderate PAH
● IVC : 1.39 cm ( Not collapsing )
● No clots.
Day : - 3
Parameters Observed value Normal value
Platelets 1.03laksh/cumm 1.5 - 40 laksh/cumm
PLATELETS COUNT : -
CT CHEST PLAIN : -
● History of Cough and Haemoptysis
● Extensive surgical emphymatous changes in chest wall
● Mild pneumomediastinum
● Consolidations in right middle lobe and lingula of left lung
● Mild bacterial pleural effusion with underlying lung collapse
● Large cavity lesion with fluid level and surrounding satellite nodular infiltrate with cavity seen involving
right upper lobe , possible tubular etiology however follow up needed
Day : - 4SERUM ELECTROLYTES: -
Parameters Observed value Normal value
Albumin 1.8g/dL 3.5 - 5.0g /dL
C.REACTIVE PROTEIN : -
Parameters Observed value Normal value
C.Reactive protein 200.6mg / dL <10 mg /dL
Day : - 5PLEURAL FLUID FOR LDH : -
Parameters Observed value Normal value
Pleural fluid for LDH 334 IU / L Physician co- relates.
SPUTUM SAMPLE TEST : -
● Negative bacilli in single and pair ;few budding yeast
● Manual cell's are observed.
Note : - From day 6, 7and 8 all parameters are observed normal
Day : - 9
Parameters Observed value Normal value
Sodium 133mmol/L 135.0 - 145.0 mmol/L
Leukocyte esterase Negative -
Serum creatinine 0.6 0.7 - 12mg/dL
Haemoglobin 9.7g/dL 12.0 - 15.0 g /dL
RANDOM BLOOD SUGAR 174 mg /dL 60 - 140 mg / dL
Nitrates Negative -
S.no Parameters Day – 1 Day – 2 Day – 3 Day – 4 Day – 5 Day – 6 Day – 7 Day – 8 Day – 9
1 B.P
(mm of Hg)
130/90 140/90 130/80 140/90 130/80 120/80 130/80 130/90 120/80
2 SpO2 95% 96% 100% 100% 98% 94% 95% 98% 98%
3 R.R 24 20 26 24 20 20 20 20 23
4 PULSE 100 92 100 102 115 90 112 86 97
5 TEMP 99 98.5 98.6 98.6 99.3 99 98.3 98 98.6
Vitals :
Assement :
● From subjective and objective evidences and some case relevant
studies an assessment was made and patient was diagnosed with
PULMONARY KOCHS with SECONDARY PNEUMONIA
★ Tuberculosis (TB) is caused by infection with Mycobacterium tuberculosis (MTB), which is part of
a complex of organisms including M. bovis (reservoir cattle) and M. africanum (reservoir humans).
★ The resurgence in TB in the UK observed over the latter part of the last century has finally halted
and notification of TB has fallen by around 1.5% per year since 2000.
Causes : -
● Patient-related
➔ Age (children > young adults < elderly)
➔ First-generation immigrants from high-prevalence countries
➔ Close contacts of patients with smear-positive pulmonary TB
➔ Overcrowding (prisons, collective dormitories); homelessness (doss houses and hostels)
PULMONARY KOCHS (TB)
➔ Chest X-ray evidence of self-healed TB
➔ Primary infection < 1 year previously
➔ Smoking: cigarettes, bidis (Indian cigarettes made of tobacco wrapped in temburini leaves) and
cannabis
● Associated diseases
➔ Immunosuppression: HIV, anti-tumour necrosis factor (TNF) and
other biologic therapies, high-dose glucocorticoids, cytotoxic agents
➔ Malignancy (especially lymphoma and leukaemia)
➔ Diabetes mellitus
➔ Chronic kidney disease
➔ Silicosis
➔ Gastrointestinal disease associated with malnutrition (gastrectomy,
jejuno-ileal bypass, cancer of the pancreas, malabsorption)
➔ Deficiency of vitamin D or A
➔ Recent measles in children.
Signs and symptoms : -
➢ Chronic cough, often with haemoptysis
➢ Pyrexia of unknown origin
➢ Unresolved pneumonia
➢ Exudative pleural effusion
➢ Asymptomatic (diagnosis on chest X-ray)
➢ Weight loss, general debility
➢ Spontaneous pneumothorax.
Diagnosis : - Specimens required
Pulmonary
● Sputum* (induced with nebulised hypertonic saline if patient not
expectorating)
● Bronchoscopy with washings or BAL(BAL = bronchoalveolar lavage)
● Gastric washing* (mainly used for children)
Extrapulmonary
● Fluid examination (cerebrospinal, ascitic, pleural, pericardial, joint): yield classically very low
● Tissue biopsy (from affected site): bone marrow/liver may be diagnostic in disseminated disease
Diagnostic tests
● Tuberculin skin test: low sensitivity/specificity; useful only in primary or deep-seated infection
● Stain
1. Ziehl–Neelsen
2. Auramine fluorescence
● Nucleic acid amplification
● Culture
1. Solid media (Löwenstein–Jensen, Middlebrook)
2. Liquid media (e.g.MGIT = mycobacteria growth indicator tube)
● Pleural fluid: adenosine deaminase
● Response to empirical antituberculous drugs (usually seen after 5–10 days)
Baseline blood tests
● Full blood count, C-reactive protein, erythrocyte sedimentation rate, urea and electrolytes, liver function tests
Note : - *At least two but preferably three, including an early morning sample.
➢ Pneumonia is as an acute respiratory illness associated with recently developed radiological pulmonary
shadowing that may besegmental, lobar or multilobar.
➢ The context in which pneumonia develops is highly suggestive of the likely organism(s) involved; therefore,
pneumonias are usually classified as community- or hospital-acquired, or those occurring in
immunocompromised hosts.
➢ ‘Lobar pneumonia’ is a radiological and pathological term referring to homogeneous consolidation of one or
more lung lobes, often with associated pleural inflammation; bronchopneumonia refers to more patchy
alveolar consolidation associated with bronchial and bronchiolar inflammation, often affecting both lower
lobes.
Causes : -
★ Cigarette smoking
★ Upper respiratory tract infections
★ Alcohol
★ Glucocorticoid therapy
★ Old age
SECONDARY PNEUMONIA
★ Recent influenza infection
★ Pre-existing lung disease
★ HIV
★ Indoor air pollution.
Organisms causing pneumonia : -
Bacterias
1. Streptococcus pneumoniae
2. Mycoplasma pneumoniae
3. Legionella pneumophila
4. Chlamydia pneumoniae
5. Haemophilus influenzae
6. Staphylococcus aureus
7. Chlamydia psittaci
8. Coxiella burnetii (Q fever)
9. Klebsiella pneumonia (Freidländer’s bacillus)
Viruses
1. Influenza, parainfluenza
2. Measles
3. Herpes simplex
4. Varicella
5. Adenovirus
6. Cytomegalovirus
7. Coronaviruses (SARS-CoV and MERS-CoV)(MERS = Middle East respiratory syndrome;
SARS = severe acute respiratory syndrome).
Signs and symptoms : -
● Cough with large amounts of sputum, sometimes fetid and blood-stained
● Pleural pain common
● Sudden expectoration of copious amounts of foul sputum if abscess ruptures into a bronchus
● High remittent pyrexia
● Profound systemic upset
● Digital clubbing may develop quickly (10–14 days)
● Consolidation on chest examination; signs of cavitation rarely found
● Pleural rub common
● Rapid deterioration in general health, with marked weight loss if not adequately treated.
Diagnosis : -
★ Pulmonary infarction
★ Pulmonary/pleural tuberculosis
★ Pulmonary oedema (can be unilateral)
★ Pulmonary eosinophilia.
★ Malignancy: bronchoalveolar cell carcinoma
★ Cryptogenic organising pneumonia/bronchiolitis obliterans organising pneumonia (COP/BOOP)
Full blood count
★ Very high (> 20 × 109/L) or low (< 4 × 109/L) white cell count: marker of severity
★ Neutrophil leucocytosis > 15 × 109/L: suggests bacterial aetiology
★ Haemolytic anaemia: occasional complication of Mycoplasma
Urea and electrolytes
★ Urea > 7 mmol/L (~20 mg/dL): marker of severity
★ Hyponatraemia: marker of severity
Liver function tests
★ Abnormal if basal pneumonia inflames liver
★ Hypoalbuminaemia: marker of severityErythrocyte sedimentation rate/C-reactive protein
★ Non-specifically elevated
Blood culture
★ Bacteraemia: marker of severity
Cold agglutinins
★ Positive in 50% of patients with Mycoplasma
Atrial blood gases
★ Measure when SaO2 < 93% or when clinical features are severe, to assess ventilatory failure or acidosis
Blood
Lobar pneumonia
➔ Patchy opacification evolves into homogeneous consolidation of affected lobe
➔ Air bronchogram (air-filled bronchi appear lucent againsconsolidated lung tissue) may be present
Bronchopneumonia
➔ Typically patchy and segmental shadowing
Complications
➔ Para-pneumonic effusion, intrapulmonary abscess or empyema
Staphylococcus aureus
➔ Suggested by multilobar shadowing, cavitation, pneumatoceles and abscesses.
Sputum samples
➔ Gram stain, culture and antimicrobial sensitivity testing.
Chest X-ray
SPUTUM
➔ Gram stain, culture and antimicrobial sensitivity testing
➔ Polymerase chain reaction for Mycoplasma pneumoniae and other atypical pathogens.
➔ Pneumococcal and/or Legionella antigen
Plural fluid
Oropharynx swab
Urine
Goals : -
● Comply with therapeutic regimen,
● No recurrence of disease,
● To have normal pulmonary function,
● To take appropriate measures to prevent disease spread,
● Measures to assist in effective coughing, maintain a patent airway,
decreasing viscosity and tenaciousness of secretions, and assist in
suctioning.
Treatment / Plan
Medications :
Drugs Generic name Dose Route Frequency Duration
Tab.Asporin + Clopidogrel
+ Atorvastatin
Tab.Asporin + Clopidogrel +
Atorvastatin
75mg /
75mg /
10mg
Po OD From day 1 to 9
Tab.Itraconazole Itraconazole - Po OD From day 1 to 9
Tab.Diltiazem Diltiazem 30mg Po TID From day 1 to 9
Tab.Bendon Vit.B6 40mg Po OD Give if required # Not given untill
Tab.Vibact DS lactobacillus - Po BID From day 1 to 9
Cap.Rabeprazole DSR Rebeprazole sodium and
domperidone
- Po OD From day 1 to 9
Inj.Human Actrapid Insulin - SC TID From day 1 to 9
Syp.Kcl Potassium chloride 10ml Po TID From day 1 to 9
Drugs Generic names Dose Route Frequency Duration
Neb with Duolin Levosalbutamol Tartarat - 50 mcg
Ipratropium Bromide - 20 mcg
- Nasal TID From day 1 to 9
Neb with Budecort Budesonide 0.5 mg / 1 mg - Nasal BID From day 1 to 9
Inj.Meropenam Meropenem Trihydrate and
Sterile Sodium Carbonate (Sodium 90.2
mg)
1gm I.V Q8H From day 2nd to 9th
Inj.Clindomycin clindamycin phosphate 60mg I.V Q8H From day 3rd to 9th
Neb.Mucomix Acetylcysteine - Nasal Q8H From day 2nd to 9th
Inj.Vit.C Vit.c 1.5gm I.V Q8H From day 2nd to 9th
Inj.Optineuron B - complex with vitamin.B12 1Amp I.V Q24H From day 2nd to 9th
Inj.Pantoprazole Pantoprazole I.V OD Give if requird.
Albumin care Proteins, Glutamine, BCAA 's Po Q12H Given on 9th day
Drugs Indication Standard dose
Tab.Asporin + Clopidogrel + Atorvastatin Anti platelet effect 81 – 325 mg + 75 – 325 mg + 10 –
80 mg / day
Itraconazole Anti – fungal 200 – 400 mg / day
Diltiazem Anti hypertensive 0.25 mg – 20 mg / day
Vit.B6 Vitamin supplement ---------
lactobacillus Probiotic 1 – 2 capsules / day
Rebeprazole sodium and domperidone GERD (Gastroesophageal reflux disease ) 60mg / OD + 10 - 20 mg / day
Insulin Hyper glycemia ( Harmonal supplement ) 0.5 – 1 unit/kg
Potassium chloride Hypokalemia 40 – 100 meq
Drugs Indication Standard dose
Levosalbutamol Tartarat - 50 mcg
Ipratropium Bromide - 20 mcg
bronchodilators 4mg + 500mcg / day
Budesonide Anti asthamatic 180 – 600 mcg / day
Meropenem Trihydrate and
Sterile Sodium Carbonate
Antibiotic 500mg + 90.2mg / day
clindamycin phosphate Antibiotic 150 – 300 mg for every 6 hrs
Acetylcysteine Mucociliary clearance 200 - 600mg / day
Vit.c Vitamin supplement -------------
B - complex with vitamin.B12 Vitamin supplement -----------
Pantoprazole Anti ulcer 40 mg / OD
Proteins, Glutamine, BCAA 's Proteins and amino acids
supplements
--------------
Patient counseling :
• Avoid eating fatty food.
• Maintain an ideal body weight.
• Do exercise daily for 30 mins.
• Avoid taking Cola beverages.
• Maintain healthy diet.
• Avoid taking Banana.
• Avoid taking Grape fruit juice and Grape fruits.
• Avoid exposure to second-hand smoke.
Pharmacist intervention :
1) Usually 2 antacids are not preferable because they cause therapeutic duplication.
2) Usually 4 vitamin supplements are not preferred because they can cause therapeutic duplication.
3) Should not take Diltiazem and Insulin at a time because they can cause severe hypoglycemia.
4) Should not take Itraconazole and budesonide simultaneously bcz they can cause Raise in B.P.
5) Should not take Itraconazole and Rabeprazole simultaneously Bcz they can cause less effective
against fungal species.
6) Insulin and syp.Kcl are not used together bcz they can cause increased hypoglycemia.
7) Should not take Diltiazem and Budesonide together Bcz they can cause Sever asthma attack.
TB and Pneumonia by rxpharmedico.in

More Related Content

What's hot

Covid-19 Clinical Case: Lessons & Recommendations-updated Jan 2021
Covid-19 Clinical Case:  Lessons & Recommendations-updated Jan 2021Covid-19 Clinical Case:  Lessons & Recommendations-updated Jan 2021
Covid-19 Clinical Case: Lessons & Recommendations-updated Jan 2021Imad Hassan
 
Advance Management of COVID-19: RECOVERY Trial
Advance Management of COVID-19: RECOVERY TrialAdvance Management of COVID-19: RECOVERY Trial
Advance Management of COVID-19: RECOVERY TrialAshiqur Rahman
 
Pediatric Community Acquired Pneumonia
Pediatric Community Acquired PneumoniaPediatric Community Acquired Pneumonia
Pediatric Community Acquired PneumoniaAgie Santos
 
CASE presentation & TOPIC discussion
CASE presentation & TOPIC discussionCASE presentation & TOPIC discussion
CASE presentation & TOPIC discussionsarita pandey
 
Interesting Case presentations
Interesting Case presentationsInteresting Case presentations
Interesting Case presentationsGamal Agmy
 
Case on Urosepsis
Case on UrosepsisCase on Urosepsis
Case on UrosepsisSUNIL NAYAK
 
Covid 19 infection and management
Covid 19 infection and managementCovid 19 infection and management
Covid 19 infection and managementParisha Chaudhari
 
Toxic case scenarios
Toxic case scenariosToxic case scenarios
Toxic case scenariosfarranajwa
 
Fever in icu by dr. armaan singh
Fever in icu by dr. armaan singhFever in icu by dr. armaan singh
Fever in icu by dr. armaan singhDr. Armaan Singh
 
COPD with RV failure - Case Presentation
COPD with RV failure - Case PresentationCOPD with RV failure - Case Presentation
COPD with RV failure - Case PresentationFlemin Thomas
 
Case history of amiodarone induced pulmonary toxicity
Case history of amiodarone induced pulmonary toxicityCase history of amiodarone induced pulmonary toxicity
Case history of amiodarone induced pulmonary toxicitymohammed sediq
 
Tappcon 2019 grand rounds
Tappcon 2019 grand roundsTappcon 2019 grand rounds
Tappcon 2019 grand roundsKamal Bharathi
 
Case Presentation MAI
Case Presentation MAICase Presentation MAI
Case Presentation MAIJoseph Helms
 

What's hot (20)

Covid-19 Clinical Case: Lessons & Recommendations-updated Jan 2021
Covid-19 Clinical Case:  Lessons & Recommendations-updated Jan 2021Covid-19 Clinical Case:  Lessons & Recommendations-updated Jan 2021
Covid-19 Clinical Case: Lessons & Recommendations-updated Jan 2021
 
ATS CAP guidelines
ATS CAP guidelinesATS CAP guidelines
ATS CAP guidelines
 
Advance Management of COVID-19: RECOVERY Trial
Advance Management of COVID-19: RECOVERY TrialAdvance Management of COVID-19: RECOVERY Trial
Advance Management of COVID-19: RECOVERY Trial
 
Tuberculosis with a case presentation
Tuberculosis with a case presentationTuberculosis with a case presentation
Tuberculosis with a case presentation
 
Pediatric Community Acquired Pneumonia
Pediatric Community Acquired PneumoniaPediatric Community Acquired Pneumonia
Pediatric Community Acquired Pneumonia
 
CASE presentation & TOPIC discussion
CASE presentation & TOPIC discussionCASE presentation & TOPIC discussion
CASE presentation & TOPIC discussion
 
Interesting Case presentations
Interesting Case presentationsInteresting Case presentations
Interesting Case presentations
 
Covid 19 Management
Covid 19 ManagementCovid 19 Management
Covid 19 Management
 
Case on Urosepsis
Case on UrosepsisCase on Urosepsis
Case on Urosepsis
 
SICKLE CELL1(1)
SICKLE CELL1(1)SICKLE CELL1(1)
SICKLE CELL1(1)
 
Covid 19 infection and management
Covid 19 infection and managementCovid 19 infection and management
Covid 19 infection and management
 
Tuberculosis cases
Tuberculosis casesTuberculosis cases
Tuberculosis cases
 
Toxic case scenarios
Toxic case scenariosToxic case scenarios
Toxic case scenarios
 
Fever in icu by dr. armaan singh
Fever in icu by dr. armaan singhFever in icu by dr. armaan singh
Fever in icu by dr. armaan singh
 
COPD with RV failure - Case Presentation
COPD with RV failure - Case PresentationCOPD with RV failure - Case Presentation
COPD with RV failure - Case Presentation
 
Case history of amiodarone induced pulmonary toxicity
Case history of amiodarone induced pulmonary toxicityCase history of amiodarone induced pulmonary toxicity
Case history of amiodarone induced pulmonary toxicity
 
Probable dengue
Probable dengueProbable dengue
Probable dengue
 
Tappcon 2019 grand rounds
Tappcon 2019 grand roundsTappcon 2019 grand rounds
Tappcon 2019 grand rounds
 
Aiims covid protocol
Aiims covid protocolAiims covid protocol
Aiims covid protocol
 
Case Presentation MAI
Case Presentation MAICase Presentation MAI
Case Presentation MAI
 

Similar to TB and Pneumonia by rxpharmedico.in

An Approach to a Case of Severe Pneumonia with Iron Deficiency Anemia
An Approach to a Case of Severe Pneumonia with Iron Deficiency Anemia An Approach to a Case of Severe Pneumonia with Iron Deficiency Anemia
An Approach to a Case of Severe Pneumonia with Iron Deficiency Anemia KairviRaval
 
Nephrotic and nephritic Syndrome children 7.ppt
Nephrotic and nephritic Syndrome children 7.pptNephrotic and nephritic Syndrome children 7.ppt
Nephrotic and nephritic Syndrome children 7.pptArun170190
 
Nephritic syndrome by Dukundane Alexandre
 Nephritic syndrome by Dukundane Alexandre Nephritic syndrome by Dukundane Alexandre
Nephritic syndrome by Dukundane AlexandreAlexandre DUKUNDANE
 
A Case presentation on right upper lobe pneumonia and b/l renal calculi
A Case presentation on right upper lobe pneumonia and b/l renal calculiA Case presentation on right upper lobe pneumonia and b/l renal calculi
A Case presentation on right upper lobe pneumonia and b/l renal calculiPavani555
 
Case membranous nephropathy
Case membranous nephropathyCase membranous nephropathy
Case membranous nephropathyDipesh Tamrakar
 
LAB INVESTIGATIONS IN ORAL AND MAXILLOFACIAL SURGERY
LAB INVESTIGATIONS IN ORAL AND MAXILLOFACIAL SURGERYLAB INVESTIGATIONS IN ORAL AND MAXILLOFACIAL SURGERY
LAB INVESTIGATIONS IN ORAL AND MAXILLOFACIAL SURGERYPunam Nagargoje
 
FORMATO CASO CLÍNICO U2 M4 T1.docx
FORMATO CASO CLÍNICO U2 M4 T1.docxFORMATO CASO CLÍNICO U2 M4 T1.docx
FORMATO CASO CLÍNICO U2 M4 T1.docxLissetnoeliaCaruajul
 
Case Report : Integrating Review Inflammation and Commorbid diseases
Case Report : Integrating Review Inflammation and Commorbid diseasesCase Report : Integrating Review Inflammation and Commorbid diseases
Case Report : Integrating Review Inflammation and Commorbid diseasesSoroy Lardo
 
Approach to Sepsis & Septic Shock in Emergency Medicine.
Approach to Sepsis & Septic Shock in Emergency Medicine.Approach to Sepsis & Septic Shock in Emergency Medicine.
Approach to Sepsis & Septic Shock in Emergency Medicine.AngelGovekar
 
Sinus Bradicardia on grade II dengue hemorragic fever.pptx
Sinus Bradicardia on grade II dengue hemorragic fever.pptxSinus Bradicardia on grade II dengue hemorragic fever.pptx
Sinus Bradicardia on grade II dengue hemorragic fever.pptxSyahrulAdzim
 
Management of dengue
Management of dengueManagement of dengue
Management of dengueRahul Abraham
 
'Pulmonary eosinophillia.ppt.pptx
'Pulmonary eosinophillia.ppt.pptx'Pulmonary eosinophillia.ppt.pptx
'Pulmonary eosinophillia.ppt.pptxNagaChandrikaPallam
 
Acute glomerulonephritis for UGs
Acute glomerulonephritis for UGsAcute glomerulonephritis for UGs
Acute glomerulonephritis for UGsCSN Vittal
 
Case presentation on thrombocytopenia leading to dengue
Case presentation on thrombocytopenia leading to dengueCase presentation on thrombocytopenia leading to dengue
Case presentation on thrombocytopenia leading to dengueShivaji University
 
FN, sepsis and shock
FN, sepsis and shockFN, sepsis and shock
FN, sepsis and shockderosaMSKCC
 

Similar to TB and Pneumonia by rxpharmedico.in (20)

Nephrotic.pptx
Nephrotic.pptxNephrotic.pptx
Nephrotic.pptx
 
An Approach to a Case of Severe Pneumonia with Iron Deficiency Anemia
An Approach to a Case of Severe Pneumonia with Iron Deficiency Anemia An Approach to a Case of Severe Pneumonia with Iron Deficiency Anemia
An Approach to a Case of Severe Pneumonia with Iron Deficiency Anemia
 
Interesting Case of Rowells syndrome
Interesting Case of Rowells syndromeInteresting Case of Rowells syndrome
Interesting Case of Rowells syndrome
 
Nephrotic and nephritic Syndrome children 7.ppt
Nephrotic and nephritic Syndrome children 7.pptNephrotic and nephritic Syndrome children 7.ppt
Nephrotic and nephritic Syndrome children 7.ppt
 
Nephritic syndrome by Dukundane Alexandre
 Nephritic syndrome by Dukundane Alexandre Nephritic syndrome by Dukundane Alexandre
Nephritic syndrome by Dukundane Alexandre
 
A Case presentation on right upper lobe pneumonia and b/l renal calculi
A Case presentation on right upper lobe pneumonia and b/l renal calculiA Case presentation on right upper lobe pneumonia and b/l renal calculi
A Case presentation on right upper lobe pneumonia and b/l renal calculi
 
Case membranous nephropathy
Case membranous nephropathyCase membranous nephropathy
Case membranous nephropathy
 
LAB INVESTIGATIONS IN ORAL AND MAXILLOFACIAL SURGERY
LAB INVESTIGATIONS IN ORAL AND MAXILLOFACIAL SURGERYLAB INVESTIGATIONS IN ORAL AND MAXILLOFACIAL SURGERY
LAB INVESTIGATIONS IN ORAL AND MAXILLOFACIAL SURGERY
 
Sepsis
SepsisSepsis
Sepsis
 
FORMATO CASO CLÍNICO U2 M4 T1.docx
FORMATO CASO CLÍNICO U2 M4 T1.docxFORMATO CASO CLÍNICO U2 M4 T1.docx
FORMATO CASO CLÍNICO U2 M4 T1.docx
 
Case Report : Integrating Review Inflammation and Commorbid diseases
Case Report : Integrating Review Inflammation and Commorbid diseasesCase Report : Integrating Review Inflammation and Commorbid diseases
Case Report : Integrating Review Inflammation and Commorbid diseases
 
Approach to Sepsis & Septic Shock in Emergency Medicine.
Approach to Sepsis & Septic Shock in Emergency Medicine.Approach to Sepsis & Septic Shock in Emergency Medicine.
Approach to Sepsis & Septic Shock in Emergency Medicine.
 
Sinus Bradicardia on grade II dengue hemorragic fever.pptx
Sinus Bradicardia on grade II dengue hemorragic fever.pptxSinus Bradicardia on grade II dengue hemorragic fever.pptx
Sinus Bradicardia on grade II dengue hemorragic fever.pptx
 
Management of dengue
Management of dengueManagement of dengue
Management of dengue
 
'Pulmonary eosinophillia.ppt.pptx
'Pulmonary eosinophillia.ppt.pptx'Pulmonary eosinophillia.ppt.pptx
'Pulmonary eosinophillia.ppt.pptx
 
A Case of Henoch-Schonlein Purpura
A Case of Henoch-Schonlein PurpuraA Case of Henoch-Schonlein Purpura
A Case of Henoch-Schonlein Purpura
 
Acute glomerulonephritis for UGs
Acute glomerulonephritis for UGsAcute glomerulonephritis for UGs
Acute glomerulonephritis for UGs
 
Case presentation on thrombocytopenia leading to dengue
Case presentation on thrombocytopenia leading to dengueCase presentation on thrombocytopenia leading to dengue
Case presentation on thrombocytopenia leading to dengue
 
cerebral toxoplasmosis
cerebral toxoplasmosiscerebral toxoplasmosis
cerebral toxoplasmosis
 
FN, sepsis and shock
FN, sepsis and shockFN, sepsis and shock
FN, sepsis and shock
 

More from NOM KUMAR NAIK BHUKYA

More from NOM KUMAR NAIK BHUKYA (15)

DIRECT THROMBIN INHIBITORS.pptx
DIRECT THROMBIN INHIBITORS.pptxDIRECT THROMBIN INHIBITORS.pptx
DIRECT THROMBIN INHIBITORS.pptx
 
HIV & AIDS BY Dr.Nom Kumar Naik.pptx
HIV & AIDS BY Dr.Nom Kumar Naik.pptxHIV & AIDS BY Dr.Nom Kumar Naik.pptx
HIV & AIDS BY Dr.Nom Kumar Naik.pptx
 
MALARIA
MALARIAMALARIA
MALARIA
 
Pharmacokinetic considerastions
Pharmacokinetic considerastionsPharmacokinetic considerastions
Pharmacokinetic considerastions
 
Renal impairment 1
Renal impairment 1Renal impairment 1
Renal impairment 1
 
VIRAL HEPATITIS by NOM KUMAR NAIK
VIRAL HEPATITIS  by NOM KUMAR NAIKVIRAL HEPATITIS  by NOM KUMAR NAIK
VIRAL HEPATITIS by NOM KUMAR NAIK
 
Cellular adaptations by NOM KUMAR NAIK
Cellular adaptations by NOM KUMAR NAIKCellular adaptations by NOM KUMAR NAIK
Cellular adaptations by NOM KUMAR NAIK
 
A Case study on OSTEOARTHRITIS by NOM
A Case study on OSTEOARTHRITIS by NOM  A Case study on OSTEOARTHRITIS by NOM
A Case study on OSTEOARTHRITIS by NOM
 
Thin layer chromatography by NOM
Thin layer chromatography by NOM Thin layer chromatography by NOM
Thin layer chromatography by NOM
 
PAPER CHROMATOGRAPHY BY Rx PHARMEDICO
PAPER CHROMATOGRAPHY BY Rx PHARMEDICO PAPER CHROMATOGRAPHY BY Rx PHARMEDICO
PAPER CHROMATOGRAPHY BY Rx PHARMEDICO
 
Hypersensitivity 3, 4 PATHOPHYSIOLOGY BY NOM NAIK
Hypersensitivity 3, 4 PATHOPHYSIOLOGY BY NOM NAIK Hypersensitivity 3, 4 PATHOPHYSIOLOGY BY NOM NAIK
Hypersensitivity 3, 4 PATHOPHYSIOLOGY BY NOM NAIK
 
SIGNIFICANT OF TOXOIDS IN ACTIVE IMMUNITY BY NOM KUMAR NAIK
SIGNIFICANT OF TOXOIDS IN ACTIVE IMMUNITY BY  NOM KUMAR NAIKSIGNIFICANT OF TOXOIDS IN ACTIVE IMMUNITY BY  NOM KUMAR NAIK
SIGNIFICANT OF TOXOIDS IN ACTIVE IMMUNITY BY NOM KUMAR NAIK
 
Immunodeficiency disorder by nom naik
Immunodeficiency disorder by nom naikImmunodeficiency disorder by nom naik
Immunodeficiency disorder by nom naik
 
Kwashiorkor wps office
Kwashiorkor wps officeKwashiorkor wps office
Kwashiorkor wps office
 
Chf case presentation by BHUKYA NOM KUMAR NAIK
Chf case presentation by BHUKYA NOM KUMAR NAIK Chf case presentation by BHUKYA NOM KUMAR NAIK
Chf case presentation by BHUKYA NOM KUMAR NAIK
 

Recently uploaded

Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfUmakantAnnand
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsKarinaGenton
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17Celine George
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppCeline George
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting DataJhengPantaleon
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 

Recently uploaded (20)

Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.Compdf
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its Characteristics
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website App
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 

TB and Pneumonia by rxpharmedico.in

  • 1. VIGNAN PHARMACY COLLEGE, VADLAMUDI A case study on PNEUMONIA and TUBERCULOSIS By B.NOM KUMAR NAIK, 17AB1T0005.
  • 2. CASE STUDY ● A 77 years old male patient was admitted in hospital with chief complaints of Cough with Hemoptysis, decreased apatite and known case of Pulmonary Koch's with Secondary pneumonia ( Fungal - Candida + Klebsiella pneumonia )
  • 3. S O A P NOTES : Patient details : - Name : - xxx Age : - 77 years Gender : - Male Subjective evidences : Chief complaints : ❑ Cough with Hemoptysis , ❑ Decreased apatite .
  • 4. Past history : 1. Hypertension, 2. Diabetes mellitus - 2, 3. Diabetic nephropathy with severe proteinuria, 4. Anemia 5. Generalized surgical emphysema 6. Hepatitis ( ATT Induced ) 7. Hypokalemia - improved .
  • 5. Past medical history : 1. Inj.Colistin - 1miu ….IV…..TID 2. Inj.Clindamycin - 600mg ….IV….TID 3. Inj.Capsofungin - OD 4. ATT Regimen 5. Tab.Atraconazole - 400mg….IOB Family history : ● NIL.
  • 6. Allergies : ● Not known ● Ex - Smoker, ● Ex - Alcoholic. Social / personal history :
  • 7. 1.Vitals : Objective evidences : ● B.P : - 160/90mm Hg ● R.R : - 15Cycles/min ● P.R : - 106 Beats/min ● Temp : - 98.6 F ● SpO2 : - 82 % ● Height : - 160cm ● Weight : - 90 kg ● BMI : - 35.2 ( Obese )
  • 8. 2.Clinical examinations :  RS : BAE +  Abdomen : Soft  CVS : S1 , S2 +  CNS : C & C
  • 9. 3.Investigations : 1. COMPLETE BLOOD COUNT ( CBC ) 2. SERUM ELECTROLYTES 3. LIVER FUNCTION TEST ( LFT ) 4. BED SIDE ECHO 5. CT CHEST PLAIN 6. CHEST X - RAY 7. SPUTUM SAMPLE TEST 8. ECG 9. PLEURAL FLUID FOR LDH 10.RANDOM BLOOD SUGAR 11.C - REACTIVE PROTEIN.
  • 10. COMPLETE BLOOD COUNT : - Parameters Observed value Normal value WBC 3,400cells/cumm 4000- 11000cells/cumm Haemoglobin 8.8g/dL 12.0 - 15.0 g/L Day : - 1
  • 11. Parameters Observed value Normal value Sodium 131 mmol/L 135.0 - 145 mmol/ L Potassium 2.8 mmol/ L 3.5 - 4.5 mmol/L Serum creatinine 1.0mg/dl 0.7 - 1.2 mg/dl SERUM ELECTROLYTES: -
  • 12. SERUM ELECTROLYTES : - Parameters Observed value Normal value Sodium 131 mmol/L 135.0 - 145 mmol/ L Day : - 2 LIVER FUNCTION TEST : - Parameters Observed value Normal value Total bilirubin 1.9mg/dL 0.2 - 1.3mg / dL
  • 13. BED SIDE ECHO : - ● Very poor echo windo ● Mild concentric LVH ● No obvious RWMA ● Grade - 1 Diastolic dysfunction of LVH ● AV Sclerosis / TriviLAAR ● Mild TR / Moderate PAH ● IVC : 1.39 cm ( Not collapsing ) ● No clots.
  • 14. Day : - 3 Parameters Observed value Normal value Platelets 1.03laksh/cumm 1.5 - 40 laksh/cumm PLATELETS COUNT : - CT CHEST PLAIN : - ● History of Cough and Haemoptysis ● Extensive surgical emphymatous changes in chest wall ● Mild pneumomediastinum ● Consolidations in right middle lobe and lingula of left lung ● Mild bacterial pleural effusion with underlying lung collapse ● Large cavity lesion with fluid level and surrounding satellite nodular infiltrate with cavity seen involving right upper lobe , possible tubular etiology however follow up needed
  • 15. Day : - 4SERUM ELECTROLYTES: - Parameters Observed value Normal value Albumin 1.8g/dL 3.5 - 5.0g /dL C.REACTIVE PROTEIN : - Parameters Observed value Normal value C.Reactive protein 200.6mg / dL <10 mg /dL
  • 16. Day : - 5PLEURAL FLUID FOR LDH : - Parameters Observed value Normal value Pleural fluid for LDH 334 IU / L Physician co- relates. SPUTUM SAMPLE TEST : - ● Negative bacilli in single and pair ;few budding yeast ● Manual cell's are observed. Note : - From day 6, 7and 8 all parameters are observed normal
  • 17. Day : - 9 Parameters Observed value Normal value Sodium 133mmol/L 135.0 - 145.0 mmol/L Leukocyte esterase Negative - Serum creatinine 0.6 0.7 - 12mg/dL Haemoglobin 9.7g/dL 12.0 - 15.0 g /dL RANDOM BLOOD SUGAR 174 mg /dL 60 - 140 mg / dL Nitrates Negative -
  • 18. S.no Parameters Day – 1 Day – 2 Day – 3 Day – 4 Day – 5 Day – 6 Day – 7 Day – 8 Day – 9 1 B.P (mm of Hg) 130/90 140/90 130/80 140/90 130/80 120/80 130/80 130/90 120/80 2 SpO2 95% 96% 100% 100% 98% 94% 95% 98% 98% 3 R.R 24 20 26 24 20 20 20 20 23 4 PULSE 100 92 100 102 115 90 112 86 97 5 TEMP 99 98.5 98.6 98.6 99.3 99 98.3 98 98.6 Vitals :
  • 19. Assement : ● From subjective and objective evidences and some case relevant studies an assessment was made and patient was diagnosed with PULMONARY KOCHS with SECONDARY PNEUMONIA
  • 20. ★ Tuberculosis (TB) is caused by infection with Mycobacterium tuberculosis (MTB), which is part of a complex of organisms including M. bovis (reservoir cattle) and M. africanum (reservoir humans). ★ The resurgence in TB in the UK observed over the latter part of the last century has finally halted and notification of TB has fallen by around 1.5% per year since 2000. Causes : - ● Patient-related ➔ Age (children > young adults < elderly) ➔ First-generation immigrants from high-prevalence countries ➔ Close contacts of patients with smear-positive pulmonary TB ➔ Overcrowding (prisons, collective dormitories); homelessness (doss houses and hostels) PULMONARY KOCHS (TB)
  • 21. ➔ Chest X-ray evidence of self-healed TB ➔ Primary infection < 1 year previously ➔ Smoking: cigarettes, bidis (Indian cigarettes made of tobacco wrapped in temburini leaves) and cannabis ● Associated diseases ➔ Immunosuppression: HIV, anti-tumour necrosis factor (TNF) and other biologic therapies, high-dose glucocorticoids, cytotoxic agents ➔ Malignancy (especially lymphoma and leukaemia) ➔ Diabetes mellitus ➔ Chronic kidney disease ➔ Silicosis ➔ Gastrointestinal disease associated with malnutrition (gastrectomy, jejuno-ileal bypass, cancer of the pancreas, malabsorption) ➔ Deficiency of vitamin D or A ➔ Recent measles in children.
  • 22. Signs and symptoms : - ➢ Chronic cough, often with haemoptysis ➢ Pyrexia of unknown origin ➢ Unresolved pneumonia ➢ Exudative pleural effusion ➢ Asymptomatic (diagnosis on chest X-ray) ➢ Weight loss, general debility ➢ Spontaneous pneumothorax. Diagnosis : - Specimens required Pulmonary ● Sputum* (induced with nebulised hypertonic saline if patient not expectorating) ● Bronchoscopy with washings or BAL(BAL = bronchoalveolar lavage) ● Gastric washing* (mainly used for children)
  • 23. Extrapulmonary ● Fluid examination (cerebrospinal, ascitic, pleural, pericardial, joint): yield classically very low ● Tissue biopsy (from affected site): bone marrow/liver may be diagnostic in disseminated disease Diagnostic tests ● Tuberculin skin test: low sensitivity/specificity; useful only in primary or deep-seated infection ● Stain 1. Ziehl–Neelsen 2. Auramine fluorescence ● Nucleic acid amplification ● Culture 1. Solid media (Löwenstein–Jensen, Middlebrook) 2. Liquid media (e.g.MGIT = mycobacteria growth indicator tube) ● Pleural fluid: adenosine deaminase ● Response to empirical antituberculous drugs (usually seen after 5–10 days) Baseline blood tests ● Full blood count, C-reactive protein, erythrocyte sedimentation rate, urea and electrolytes, liver function tests Note : - *At least two but preferably three, including an early morning sample.
  • 24. ➢ Pneumonia is as an acute respiratory illness associated with recently developed radiological pulmonary shadowing that may besegmental, lobar or multilobar. ➢ The context in which pneumonia develops is highly suggestive of the likely organism(s) involved; therefore, pneumonias are usually classified as community- or hospital-acquired, or those occurring in immunocompromised hosts. ➢ ‘Lobar pneumonia’ is a radiological and pathological term referring to homogeneous consolidation of one or more lung lobes, often with associated pleural inflammation; bronchopneumonia refers to more patchy alveolar consolidation associated with bronchial and bronchiolar inflammation, often affecting both lower lobes. Causes : - ★ Cigarette smoking ★ Upper respiratory tract infections ★ Alcohol ★ Glucocorticoid therapy ★ Old age SECONDARY PNEUMONIA
  • 25. ★ Recent influenza infection ★ Pre-existing lung disease ★ HIV ★ Indoor air pollution. Organisms causing pneumonia : - Bacterias 1. Streptococcus pneumoniae 2. Mycoplasma pneumoniae 3. Legionella pneumophila 4. Chlamydia pneumoniae 5. Haemophilus influenzae 6. Staphylococcus aureus 7. Chlamydia psittaci 8. Coxiella burnetii (Q fever) 9. Klebsiella pneumonia (Freidländer’s bacillus)
  • 26. Viruses 1. Influenza, parainfluenza 2. Measles 3. Herpes simplex 4. Varicella 5. Adenovirus 6. Cytomegalovirus 7. Coronaviruses (SARS-CoV and MERS-CoV)(MERS = Middle East respiratory syndrome; SARS = severe acute respiratory syndrome). Signs and symptoms : - ● Cough with large amounts of sputum, sometimes fetid and blood-stained ● Pleural pain common ● Sudden expectoration of copious amounts of foul sputum if abscess ruptures into a bronchus ● High remittent pyrexia ● Profound systemic upset
  • 27. ● Digital clubbing may develop quickly (10–14 days) ● Consolidation on chest examination; signs of cavitation rarely found ● Pleural rub common ● Rapid deterioration in general health, with marked weight loss if not adequately treated. Diagnosis : - ★ Pulmonary infarction ★ Pulmonary/pleural tuberculosis ★ Pulmonary oedema (can be unilateral) ★ Pulmonary eosinophilia. ★ Malignancy: bronchoalveolar cell carcinoma ★ Cryptogenic organising pneumonia/bronchiolitis obliterans organising pneumonia (COP/BOOP)
  • 28. Full blood count ★ Very high (> 20 × 109/L) or low (< 4 × 109/L) white cell count: marker of severity ★ Neutrophil leucocytosis > 15 × 109/L: suggests bacterial aetiology ★ Haemolytic anaemia: occasional complication of Mycoplasma Urea and electrolytes ★ Urea > 7 mmol/L (~20 mg/dL): marker of severity ★ Hyponatraemia: marker of severity Liver function tests ★ Abnormal if basal pneumonia inflames liver ★ Hypoalbuminaemia: marker of severityErythrocyte sedimentation rate/C-reactive protein ★ Non-specifically elevated Blood culture ★ Bacteraemia: marker of severity Cold agglutinins ★ Positive in 50% of patients with Mycoplasma Atrial blood gases ★ Measure when SaO2 < 93% or when clinical features are severe, to assess ventilatory failure or acidosis Blood
  • 29. Lobar pneumonia ➔ Patchy opacification evolves into homogeneous consolidation of affected lobe ➔ Air bronchogram (air-filled bronchi appear lucent againsconsolidated lung tissue) may be present Bronchopneumonia ➔ Typically patchy and segmental shadowing Complications ➔ Para-pneumonic effusion, intrapulmonary abscess or empyema Staphylococcus aureus ➔ Suggested by multilobar shadowing, cavitation, pneumatoceles and abscesses. Sputum samples ➔ Gram stain, culture and antimicrobial sensitivity testing. Chest X-ray SPUTUM
  • 30. ➔ Gram stain, culture and antimicrobial sensitivity testing ➔ Polymerase chain reaction for Mycoplasma pneumoniae and other atypical pathogens. ➔ Pneumococcal and/or Legionella antigen Plural fluid Oropharynx swab Urine
  • 31. Goals : - ● Comply with therapeutic regimen, ● No recurrence of disease, ● To have normal pulmonary function, ● To take appropriate measures to prevent disease spread, ● Measures to assist in effective coughing, maintain a patent airway, decreasing viscosity and tenaciousness of secretions, and assist in suctioning. Treatment / Plan
  • 32. Medications : Drugs Generic name Dose Route Frequency Duration Tab.Asporin + Clopidogrel + Atorvastatin Tab.Asporin + Clopidogrel + Atorvastatin 75mg / 75mg / 10mg Po OD From day 1 to 9 Tab.Itraconazole Itraconazole - Po OD From day 1 to 9 Tab.Diltiazem Diltiazem 30mg Po TID From day 1 to 9 Tab.Bendon Vit.B6 40mg Po OD Give if required # Not given untill Tab.Vibact DS lactobacillus - Po BID From day 1 to 9 Cap.Rabeprazole DSR Rebeprazole sodium and domperidone - Po OD From day 1 to 9 Inj.Human Actrapid Insulin - SC TID From day 1 to 9 Syp.Kcl Potassium chloride 10ml Po TID From day 1 to 9
  • 33. Drugs Generic names Dose Route Frequency Duration Neb with Duolin Levosalbutamol Tartarat - 50 mcg Ipratropium Bromide - 20 mcg - Nasal TID From day 1 to 9 Neb with Budecort Budesonide 0.5 mg / 1 mg - Nasal BID From day 1 to 9 Inj.Meropenam Meropenem Trihydrate and Sterile Sodium Carbonate (Sodium 90.2 mg) 1gm I.V Q8H From day 2nd to 9th Inj.Clindomycin clindamycin phosphate 60mg I.V Q8H From day 3rd to 9th Neb.Mucomix Acetylcysteine - Nasal Q8H From day 2nd to 9th Inj.Vit.C Vit.c 1.5gm I.V Q8H From day 2nd to 9th Inj.Optineuron B - complex with vitamin.B12 1Amp I.V Q24H From day 2nd to 9th Inj.Pantoprazole Pantoprazole I.V OD Give if requird. Albumin care Proteins, Glutamine, BCAA 's Po Q12H Given on 9th day
  • 34. Drugs Indication Standard dose Tab.Asporin + Clopidogrel + Atorvastatin Anti platelet effect 81 – 325 mg + 75 – 325 mg + 10 – 80 mg / day Itraconazole Anti – fungal 200 – 400 mg / day Diltiazem Anti hypertensive 0.25 mg – 20 mg / day Vit.B6 Vitamin supplement --------- lactobacillus Probiotic 1 – 2 capsules / day Rebeprazole sodium and domperidone GERD (Gastroesophageal reflux disease ) 60mg / OD + 10 - 20 mg / day Insulin Hyper glycemia ( Harmonal supplement ) 0.5 – 1 unit/kg Potassium chloride Hypokalemia 40 – 100 meq
  • 35. Drugs Indication Standard dose Levosalbutamol Tartarat - 50 mcg Ipratropium Bromide - 20 mcg bronchodilators 4mg + 500mcg / day Budesonide Anti asthamatic 180 – 600 mcg / day Meropenem Trihydrate and Sterile Sodium Carbonate Antibiotic 500mg + 90.2mg / day clindamycin phosphate Antibiotic 150 – 300 mg for every 6 hrs Acetylcysteine Mucociliary clearance 200 - 600mg / day Vit.c Vitamin supplement ------------- B - complex with vitamin.B12 Vitamin supplement ----------- Pantoprazole Anti ulcer 40 mg / OD Proteins, Glutamine, BCAA 's Proteins and amino acids supplements --------------
  • 36. Patient counseling : • Avoid eating fatty food. • Maintain an ideal body weight. • Do exercise daily for 30 mins. • Avoid taking Cola beverages. • Maintain healthy diet. • Avoid taking Banana. • Avoid taking Grape fruit juice and Grape fruits. • Avoid exposure to second-hand smoke.
  • 37. Pharmacist intervention : 1) Usually 2 antacids are not preferable because they cause therapeutic duplication. 2) Usually 4 vitamin supplements are not preferred because they can cause therapeutic duplication. 3) Should not take Diltiazem and Insulin at a time because they can cause severe hypoglycemia. 4) Should not take Itraconazole and budesonide simultaneously bcz they can cause Raise in B.P. 5) Should not take Itraconazole and Rabeprazole simultaneously Bcz they can cause less effective against fungal species. 6) Insulin and syp.Kcl are not used together bcz they can cause increased hypoglycemia. 7) Should not take Diltiazem and Budesonide together Bcz they can cause Sever asthma attack.